These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15172164)

  • 1. High efficiency entrapment of antisense oligonucleotides in liposomes.
    Stuart DD; Semple SC; Allen TM
    Methods Enzymol; 2004; 387():171-88. PubMed ID: 15172164
    [No Abstract]   [Full Text] [Related]  

  • 2. Cationic liposomes/lipids for oligonucleotide delivery: application to the inhibition of tumorigenicity of Kaposi's sarcoma by vascular endothelial growth factor antisense oligodeoxynucleotides.
    Lavigne C; Lunardi-Iskandar Y; Lebleu B; Thierry AR
    Methods Enzymol; 2004; 387():189-210. PubMed ID: 15172165
    [No Abstract]   [Full Text] [Related]  

  • 3. Requirements for delivery of active antisense oligonucleotides into cells with lipid carriers.
    Jääskeläinen I; Lappalainen K; Honkakoski P; Urtti A
    Methods Enzymol; 2004; 387():210-30. PubMed ID: 15172166
    [No Abstract]   [Full Text] [Related]  

  • 4. Folate receptor-mediated targeting of liposomal drugs to cancer cells.
    Stephenson SM; Low PS; Lee RJ
    Methods Enzymol; 2004; 387():33-50. PubMed ID: 15172156
    [No Abstract]   [Full Text] [Related]  

  • 5. The materials engineering of temperature-sensitive liposomes.
    Mills JK; Needham D
    Methods Enzymol; 2004; 387():82-113. PubMed ID: 15172159
    [No Abstract]   [Full Text] [Related]  

  • 6. Tunable pH-sensitive liposomes.
    Hafez IM; Cullis PR
    Methods Enzymol; 2004; 387():113-34. PubMed ID: 15172160
    [No Abstract]   [Full Text] [Related]  

  • 7. Preparation of poly(ethylene glycol)-grafted liposomes with ligands at the extremities of polymer chains.
    Zalipsky S; Mullah N; Qazen M
    Methods Enzymol; 2004; 387():50-69. PubMed ID: 15172157
    [No Abstract]   [Full Text] [Related]  

  • 8. Liposomal antisense oligonucleotides for cancer therapy.
    Siwak DR; Tari AM; Lopez-Berestein G
    Methods Enzymol; 2004; 387():241-53. PubMed ID: 15172168
    [No Abstract]   [Full Text] [Related]  

  • 9. Improved preparation of PEG-diortho ester-diacyl glycerol conjugates.
    Guo X; Huang Z; Szoka FC
    Methods Enzymol; 2004; 387():147-52. PubMed ID: 15172162
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis of antisense oligonucleotides conjugated to a multivalent carbohydrate cluster for cellular targeting.
    Maier MA; Yannopoulos CG; Mohamed N; Roland A; Fritz H; Mohan V; Just G; Manoharan M
    Bioconjug Chem; 2003; 14(1):18-29. PubMed ID: 12526688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells.
    Peng J; He X; Wang K; Tan W; Li H; Xing X; Wang Y
    Nanomedicine; 2006 Jun; 2(2):113-20. PubMed ID: 17292123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect.
    Zhang Y; Rong Qi X; Gao Y; Wei L; Maitani Y; Nagai T
    J Control Release; 2007 Feb; 117(2):281-90. PubMed ID: 17196291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation of 125I-oligonucleotide-long-circulation liposomes].
    Ma C; Kuang AR; Tang GS; Huang R
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):415-8. PubMed ID: 15931884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sterically stabilized ph-sensitive liposomes.
    Slepushkin V; Simões S; de Lima MC; Düzgüneş N
    Methods Enzymol; 2004; 387():134-47. PubMed ID: 15172161
    [No Abstract]   [Full Text] [Related]  

  • 15. Liposomal gels for vaginal drug delivery.
    Pavelić Z; Skalko-Basnet N; Schubert R; Jalsenjak I
    Methods Enzymol; 2004; 387():287-99. PubMed ID: 15172171
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro and in vivo tumor suppressive activity induced by human telomerase transcriptase-targeting antisense oligonucleotides mediated by cationic liposomes.
    Han M; Chen JL; Hu Y; He CL; Shuai WP; Yu JH; Chen HL; Liang WQ; Mayumi T; Shinsaku N; Gao JQ
    J Biosci Bioeng; 2008 Sep; 106(3):243-7. PubMed ID: 18929999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved formulations of antisense oligodeoxynucleotides using wrapped liposomes.
    Yamauchi M; Kusano H; Saito E; Iwata T; Nakakura M; Kato Y; Uochi T; Akinaga S; Aoki N
    J Control Release; 2006 Aug; 114(2):268-75. PubMed ID: 16860428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pegylation of liposomes favours the endosomal degradation of the delivered phosphodiester oligonucleotides.
    Remaut K; Lucas B; Braeckmans K; Demeester J; De Smedt SC
    J Control Release; 2007 Feb; 117(2):256-66. PubMed ID: 17188777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of oligonucleotides against nucleases by pegylated and non-pegylated liposomes as studied by fluorescence correlation spectroscopy.
    Remaut K; Lucas B; Braeckmans K; Sanders NN; Demeester J; De Smedt SC
    J Control Release; 2005 Dec; 110(1):212-26. PubMed ID: 16298008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator.
    Kim JY; Kim JK; Park JS; Byun Y; Kim CK
    Biomaterials; 2009 Oct; 30(29):5751-6. PubMed ID: 19656559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.